Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and ...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 24, 2024

Boeing partners with Saskatchewan Indian Institute of Technologies to elevate Indigenous education • Hithium Hosts Roundtable at the BNEF Summit New York, Discussing Next Generation Battery Energy Storage System • Kide Science Is Named an Approved Preschool Curriculum for the State of Missouri • Compass Group Reinforces Commitment to Reduce Food Waste on 8th Annual Stop Food Waste Day • TEAMSTERS LOCAL 705 MEMBERS WIN RACIAL DISCRIMINATION LAWSUIT AGAINST DHL EXPRESS • Pediatric Cancer Patients Declare "No Cape" the Winner in New Superhero Survey • MAKO Medical Partners with Rebuilding Together to Restore Home for U.S. Military Veteran • Iruka Hawaii Dolphin and Pearl Haven Celebrate Successful Marine Educational Event for Youth • First Annual Cultural Celebration Day in Lansing, Illinois Calls For Participants • Blue Shield of California's Award-Winning Wellvolution Now Offers Services to Prevent and Treat Musculoskeletal Pain and Injurie • Lingokids Named One of TIME's Best EdTech Companies of 2024 • D'FESTA LA Brings the Best of K-Pop to the US • Watercrest Senior Living Group Celebrates the Promotion of James Brassard to Director of Market Street Operations • Austin Woman Sues Apartment Complex Following Sexual Assault by Intruder • Talking Math: WPI Researcher Neil Heffernan Leads Effort To Develop AI Math Tutor • National Volunteer Week: Storyteller Shares the Joy of Reading with Kentucky Families • The Fresh Market Elevates the Food Scene in Lakewood Ranch with Newest Store • Stanford Medicine Children's Health Welcomes New Chief of the Division of Abdominal Transplantation • Transition Industries LLC and JAPAMA announce public-private partnership to develop innovative and environmentally responsible w • Goldman Sachs Executives Empower Military Children through Education

Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call

WILMINGTON, Mass. , February 09 /Businesswire/ - Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2022 financial results and provide 2023 guidance on Wednesday, February 22^nd, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, February 22^nd, at 8:30 a.m. ET.

Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at ir.criver.com. A replay will be accessible through the same website.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.